For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has recently come into focus.

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

A surprising ‘Love Is Blind’ moment put CPAP machines in the spotlight for Sleep Week 2026. Here’s what they do, how much they cost and if they’re right for you.

Snoring may signal mild sleep apnea. For Sleep Awareness Month, get 25% off the FDA-authorized eXciteOSA device through March 14.

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

I apps, the $136 billion sleep industry is changing. Read here as a sleep doctor predicts the changes to come.

SEATTLE -- Psychological evaluation before implantation of a hypoglossal nerve stimulation (HNS) device to treat obstructive sleep apnea (OSA) was associated with fewer patients wanting explant ...

The AcuPebble, developed by Imperial spinout Acurable, promises easier access to a diagnosis and savings for the health service. A wearable medical device that tests for the breathing disorder ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US adults. While there are many clinical treatments available to effectively ...

Plus, doctors’ number-one pick and their take on the devices.

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...